What is Opus Genetics's earnings yield?

Opus Genetics (IRD) reported earnings yield of -33% in Q1 2026.

How has Opus Genetics's earnings yield changed year-over-year?

Opus Genetics's earnings yield increased by 75.1% year-over-year, from -132.8% to -33%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Opus Genetics IRD Earnings yield

Earnings yield at other companies

AbbVieABBV

0.9%-0.2pp

MeiraGTx Holdings plcMGTX

-25.5%—

4D Molecular TherapeuticsFDMT

-51.5%-403pp

Opko HealthOPK

-24.6%-29.5pp

Kodiak Sciences IncKOD

-9.9%-4.8pp

Regeneron PharmaceuticalsREGN

5.4%-1.1pp

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Calculated from Opus Genetics’s reported figures.

net income/market cap=-33%

Based on trailing twelve months.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's earnings yield?: Opus Genetics (IRD) reported earnings yield of -33% in Q1 2026.
How has Opus Genetics's earnings yield changed year-over-year?: Opus Genetics's earnings yield increased by 75.1% year-over-year, from -132.8% to -33%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.